EdgarLookup

Alto Neuroscience, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Savitz Adam CHIEF MEDICAL OFFICER Purchase 1,388 $13.15 $18,252 36,920 Jul 10, 2024
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Purchase 4,550 $16.56 $75,348 26,866 Mar 28, 2024
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Award / Grant 19,153 20,716 Mar 1, 2024
Etkin Amit PRESIDENT AND CEO Award / Grant 34,711 1,240,176 Mar 1, 2024
Chen Po Yu (Jeff) C 39,259 39,259 Feb 6, 2024
Etkin Amit PRESIDENT AND CEO C 11,777 1,202,340 Feb 6, 2024
Savitz Adam CHIEF MEDICAL OFFICER C 7,851 7,851 Feb 6, 2024
Cox Christopher Nixon C 588,898 588,898 Feb 6, 2024
Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Purchase 1,563 $16.00 $25,008 1,563 Feb 6, 2024
York Gwill C 23,917 23,917 Feb 6, 2024
Alpha Wave Global, LP C 1,962,995 1,962,995 Feb 6, 2024
Apeiron Investment Group Ltd. C 251,881 251,881 Feb 6, 2024